Spots Global Cancer Trial Database for Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Official Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Study ID: NCT00256932
Study Description
Brief Summary: Adults who are taking opioid therapy for persistent non-cancer pain and have resulting opioid-induced bowel dysfunction (OBD) will be randomized (1:1:1) to one 2 alvimopan arms, or to placebo. The primary objective of this phase 3 confirmatory study is to compare alvimopan with placebo for efficacy in the treatment of OBD. The primary efficacy endpoint is based on frequency of bowel movements. Subjects will be required to: (1) track their bowel movements and other bowel symptoms and (2) attend 6 clinic visits over 4 months.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Birmingham, Alabama, United States
GSK Investigational Site, Birmingham, Alabama, United States
GSK Investigational Site, Calera, Alabama, United States
GSK Investigational Site, Muscle Shoals, Alabama, United States
GSK Investigational Site, Tallassee, Alabama, United States
GSK Investigational Site, Glendale, Arizona, United States
GSK Investigational Site, Phoenix, Arizona, United States
GSK Investigational Site, Phoenix, Arizona, United States
GSK Investigational Site, Sun City, Arizona, United States
GSK Investigational Site, Tucson, Arizona, United States
GSK Investigational Site, Tucson, Arizona, United States
GSK Investigational Site, Hot Springs, Arkansas, United States
GSK Investigational Site, Little Rock, Arkansas, United States
GSK Investigational Site, Anaheim, California, United States
GSK Investigational Site, Anaheim, California, United States
GSK Investigational Site, Beuna Park, California, United States
GSK Investigational Site, Burbank, California, United States
GSK Investigational Site, Duarte, California, United States
GSK Investigational Site, Fountain Valley, California, United States
GSK Investigational Site, Huntington Beach, California, United States
GSK Investigational Site, Mission Viejo, California, United States
GSK Investigational Site, Orange, California, United States
GSK Investigational Site, Redlands, California, United States
GSK Investigational Site, San Diego, California, United States
GSK Investigational Site, San Diego, California, United States
GSK Investigational Site, San Diego, California, United States
GSK Investigational Site, Vista, California, United States
GSK Investigational Site, Waterbury, Connecticut, United States
GSK Investigational Site, Newark, Delaware, United States
GSK Investigational Site, Brandon, Florida, United States
GSK Investigational Site, Brooksville, Florida, United States
GSK Investigational Site, Deland, Florida, United States
GSK Investigational Site, Fort Meyers, Florida, United States
GSK Investigational Site, Gainsville, Florida, United States
GSK Investigational Site, Hollywood, Florida, United States
GSK Investigational Site, Jacksonville, Florida, United States
GSK Investigational Site, Jacksonville, Florida, United States
GSK Investigational Site, Jupiter, Florida, United States
GSK Investigational Site, Largo, Florida, United States
GSK Investigational Site, Melbourne, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Niceville, Florida, United States
GSK Investigational Site, North Miami, Florida, United States
GSK Investigational Site, Ocala, Florida, United States
GSK Investigational Site, Orlando, Florida, United States
GSK Investigational Site, Ormond Beach, Florida, United States
GSK Investigational Site, Sarasota, Florida, United States
GSK Investigational Site, St. Petersburg, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, West Palm Beach, Florida, United States
GSK Investigational Site, Winter Park, Florida, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Dawsonville, Georgia, United States
GSK Investigational Site, Decatur, Georgia, United States
GSK Investigational Site, Decatur, Georgia, United States
GSK Investigational Site, Marietta, Georgia, United States
GSK Investigational Site, Bloomington, Illinois, United States
GSK Investigational Site, Rockford, Illinois, United States
GSK Investigational Site, Elkhart, Indiana, United States
GSK Investigational Site, Evansville, Indiana, United States
GSK Investigational Site, Indianapolis, Indiana, United States
GSK Investigational Site, Indianapolis, Indiana, United States
GSK Investigational Site, Newburgh, Indiana, United States
GSK Investigational Site, Lexington, Kentucky, United States
GSK Investigational Site, Louisville, Kentucky, United States
GSK Investigational Site, Shreveport, Louisiana, United States
GSK Investigational Site, Baltimore, Maryland, United States
GSK Investigational Site, Elkridge, Maryland, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Detroit, Michigan, United States
GSK Investigational Site, Portage, Michigan, United States
GSK Investigational Site, Saginaw, Michigan, United States
GSK Investigational Site, Chaska, Minnesota, United States
GSK Investigational Site, Picayune, Mississippi, United States
GSK Investigational Site, Fenton, Missouri, United States
GSK Investigational Site, Manchester, Missouri, United States
GSK Investigational Site, St. Louis, Missouri, United States
GSK Investigational Site, St. Louis, Missouri, United States
GSK Investigational Site, Omaha, Nebraska, United States
GSK Investigational Site, Incline Village, Nevada, United States
GSK Investigational Site, Las Vegas, Nevada, United States
GSK Investigational Site, Las Vegas, Nevada, United States
GSK Investigational Site, Elizabeth, New Jersey, United States
GSK Investigational Site, Haddon Heights, New Jersey, United States
GSK Investigational Site, Princeton, New Jersey, United States
GSK Investigational Site, East Syracuse, New York, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, Valley Stream, New York, United States
GSK Investigational Site, Charlotte, North Carolina, United States
GSK Investigational Site, Charlotte, North Carolina, United States
GSK Investigational Site, Concord, North Carolina, United States
GSK Investigational Site, Greensboro, North Carolina, United States
GSK Investigational Site, Salisbury, North Carolina, United States
GSK Investigational Site, Wilmington, North Carolina, United States
GSK Investigational Site, Winston-Salem, North Carolina, United States
GSK Investigational Site, Cincinnati, Ohio, United States
GSK Investigational Site, Cincinnati, Ohio, United States
GSK Investigational Site, Columbus, Ohio, United States
GSK Investigational Site, Dayton, Ohio, United States
GSK Investigational Site, Dayton, Ohio, United States
GSK Investigational Site, Maumee, Ohio, United States
GSK Investigational Site, Oklahoma City, Oklahoma, United States
GSK Investigational Site, Eugene, Oregon, United States
GSK Investigational Site, Medford, Oregon, United States
GSK Investigational Site, Oregon City, Oregon, United States
GSK Investigational Site, Portland, Oregon, United States
GSK Investigational Site, Portland, Oregon, United States
GSK Investigational Site, Portland, Oregon, United States
GSK Investigational Site, Bala Cynwyd, Pennsylvania, United States
GSK Investigational Site, Nazareth, Pennsylvania, United States
GSK Investigational Site, Whitehall, Pennsylvania, United States
GSK Investigational Site, Wyomissing, Pennsylvania, United States
GSK Investigational Site, Warwick, Rhode Island, United States
GSK Investigational Site, Woonsocket, Rhode Island, United States
GSK Investigational Site, Charleston, South Carolina, United States
GSK Investigational Site, Murrells Inlet, South Carolina, United States
GSK Investigational Site, Spartanburg, South Carolina, United States
GSK Investigational Site, Arlington, Texas, United States
GSK Investigational Site, Brownwood, Texas, United States
GSK Investigational Site, Colleyville, Texas, United States
GSK Investigational Site, Galveston, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Lake Jackson, Texas, United States
GSK Investigational Site, San Antonio, Texas, United States
GSK Investigational Site, San Antonio, Texas, United States
GSK Investigational Site, Alexandria, Virginia, United States
GSK Investigational Site, Chesapeake, Virginia, United States
GSK Investigational Site, Christiansburg, Virginia, United States
GSK Investigational Site, Danville, Virginia, United States
GSK Investigational Site, Virginia Beach, Virginia, United States
GSK Investigational Site, Bellingham, Washington, United States
GSK Investigational Site, Edmonds, Washington, United States
GSK Investigational Site, Lacey, Washington, United States
GSK Investigational Site, Spokane, Washington, United States
GSK Investigational Site, Vienna, , Austria
GSK Investigational Site, Vienna, , Austria
GSK Investigational Site, Edmonton, Alberta, Canada
GSK Investigational Site, Kelowna, British Columbia, Canada
GSK Investigational Site, Langley, British Columbia, Canada
GSK Investigational Site, Saint John's, Newfoundland and Labrador, Canada
GSK Investigational Site, Halifax, Nova Scotia, Canada
GSK Investigational Site, Brampton, Ontario, Canada
GSK Investigational Site, Kitchener, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Chandler, Quebec, Canada
GSK Investigational Site, Mirabel, Quebec, Canada
GSK Investigational Site, Montreal, Quebec, Canada
GSK Investigational Site, Sherbrooke, Quebec, Canada
GSK Investigational Site, Hvidovre, , Denmark
GSK Investigational Site, Ishoj, , Denmark
GSK Investigational Site, Odense C, , Denmark
GSK Investigational Site, Tallinn, , Estonia
GSK Investigational Site, Helsinki, , Finland
GSK Investigational Site, Fellbach, Baden-Wuerttemberg, Germany
GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Villingen-Schwenningen, Baden-Wuerttemberg, Germany
GSK Investigational Site, Weinheim, Baden-Wuerttemberg, Germany
GSK Investigational Site, Augsburg, Bayern, Germany
GSK Investigational Site, Nuernberg, Bayern, Germany
GSK Investigational Site, Huettenberg, Hessen, Germany
GSK Investigational Site, Wiesbaden, Hessen, Germany
GSK Investigational Site, Schwerin, Mecklenburg-Vorpommern, Germany
GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany
GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany
GSK Investigational Site, Viersen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Witten, Nordrhein-Westfalen, Germany
GSK Investigational Site, Chemnitz, Sachsen, Germany
GSK Investigational Site, Dresden, Sachsen, Germany
GSK Investigational Site, Kiel, Schleswig-Holstein, Germany
GSK Investigational Site, Pinneberg, Schleswig-Holstein, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Cork, , Ireland
GSK Investigational Site, Gdansk, , Poland
GSK Investigational Site, Krakow, , Poland
GSK Investigational Site, Wroclaw, , Poland
GSK Investigational Site, Reading, Berkshire, United Kingdom
GSK Investigational Site, Slough, Berkshire, United Kingdom
GSK Investigational Site, Cardiff, Glamorgan, United Kingdom
GSK Investigational Site, Glasgow, Lanarkshire, United Kingdom
GSK Investigational Site, Glasgow, Lanarkshire, United Kingdom
GSK Investigational Site, Blackpool, Lancashire, United Kingdom
GSK Investigational Site, Ashford, Middlesex, United Kingdom
GSK Investigational Site, Sunbury-on-Thames, Middlesex, United Kingdom
GSK Investigational Site, Coventry, Warwickshire, United Kingdom
GSK Investigational Site, Bexhill-on-Sea, East Sussex, , United Kingdom
GSK Investigational Site, Leeds, , United Kingdom
GSK Investigational Site, London, , United Kingdom
GSK Investigational Site, Yaxley, Peterborough, , United Kingdom
GSK Investigational Site, York, , United Kingdom
Contact Details
Name: GSK Clinical Trials, MD
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
